Analyzing ARQ (NASDAQ:ARQ) and PURE Bioscience (OTCMKTS:PURE)

PURE Bioscience (OTCMKTS:PUREGet Free Report) and ARQ (NASDAQ:ARQGet Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Valuation and Earnings

This table compares PURE Bioscience and ARQ’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PURE Bioscience $1.87 million 3.89 -$3.96 million ($0.06) -1.08
ARQ $99.18 million 2.19 -$12.25 million ($0.27) -22.33

PURE Bioscience has higher earnings, but lower revenue than ARQ. ARQ is trading at a lower price-to-earnings ratio than PURE Bioscience, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

PURE Bioscience has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Comparatively, ARQ has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500.

Profitability

This table compares PURE Bioscience and ARQ’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PURE Bioscience -194.80% -717.03% -326.30%
ARQ -8.15% -4.65% -3.51%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for PURE Bioscience and ARQ, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PURE Bioscience 0 0 0 0 N/A
ARQ 0 0 0 0 N/A

Institutional & Insider Ownership

18.5% of ARQ shares are owned by institutional investors. 41.8% of PURE Bioscience shares are owned by insiders. Comparatively, 22.2% of ARQ shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

ARQ beats PURE Bioscience on 6 of the 10 factors compared between the two stocks.

About PURE Bioscience

(Get Free Report)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

About ARQ

(Get Free Report)

Arq, Inc. produces activated carbon products in North America. The company's products include granular activated carbon, powdered and granular activated carbon, and colloidal carbon products; Arq Powder Wetcake, a fine and low-ash coal waste-derived particle; and additives for air emissions control. Its products are used in various applications, including water treatment, ground water remediation, soil sediments, air emissions, and asphalt additives. The company was formerly known as Advanced Emissions Solutions, Inc. and changed its name to Arq, Inc. in February 2024. Arq, Inc. was founded in 1997 and is headquartered in Greenwood Village, Colorado.

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.